Latest Breaking News On - Lung transplant - Page 7 : vimarsana.com

Eating these fats can slow down lung fibrosis says research

University of Virginia (UVA) researchers investigated the relationship between pulmonary fibrosis and omega-3 fatty acids. Higher blood levels of omeg

Sir Roy Calne, surgeon who led first liver transplant in Europe, dies aged 93

Sir Roy Calne, the pioneering surgeon who led the first liver transplant operation in Europe in 1968, has died at the age of 93, his family said.

Sir Roy Calne, surgeon and authority on immunosuppression who carried out Europe's first liver transplant – obituary

Professor Sir Roy Calne, who has died aged 93, carried out Europe’s first liver transplant and made important contributions to the development of immunosuppressive drugs, notably the cyclosporines, which prevent organ rejection and have transformed transplantation into a major branch of surgery.

High COPD disease incidence adds to worry over Covid surge

Cherie S. Blackwell's New Book, "An Unknown Angel's Gift," is a Poignant Account Following the Lung Transplant Journey of the Author's Husband

Fulton Books author Cherie S. Blackwell, who has a lifelong love of writing poetry and reading nonfiction biographies, has completed her most recent book,...

Positivity rates climb, but testing lags in state ahead of festival season

As per the data provided by the state health department, the test positivity rate—the percentage of conducted tests that yield positive results for the infection—was 1.6 percent on Thursday, with 11 confirmed cases out of 676 total tests conducted.

Global Black Lung Disease Market Is Projected To Grow At A 14.7% Rate Through The Forecast Period

Agomab Starts Phase 1 Clinical Study for AGMB-447 in Healthy Subjects and Patients with Idiopathic Pulmonary Fibrosis

GHENT, Belgium, December 14, 2023--Agomab Therapeutics NV (‘Agomab’) today announced that it has dosed the first subject in a first-in-human Phase 1 clinical study of AGMB-447, an inhaled lung-restricted small molecule inhibitor of ALK5 (TGFβRI or ALK5). The study is evaluating AGMB-447 in healthy subjects and in patients with idiopathic pulmonary fibrosis (IPF).

WHO calls for ban on flavoured vapes; 6 ways e-cigarettes can damage health

WHO called for ban on all flavours of e-cigarettes highlighting the dangers of vaping. Here are ways vaping damages our body. | Health

LifeShare makes history as first Organ Procurement Organization to transplant perfused lungs

OKLAHOMA CITY – LifeShare of Oklahoma recently announced they achieved a historic milestone by becoming the first Organ Procurement Organization (OPO) to place lungs for transplant following independent ex vivo